Speqta AB: Redeye: Speqta - Rahalaitos Makes its Mark

Redeye reiterates its positive view on Speqta as the first quarter was
in line with our expectations. The acquisition of Rahalaitos
substantially increases the group's sales and earnings. The Corona
Crisis is, on the other hand, challenging for Speqta with lower
demand for loans, in the short-term, as the main effect. However, it
does not change our positive long-term view of the company's growth
potential, and we continue to see a substantial upside potential in
the stock.

Read more and download the research update: https://bit.ly/2WZrHxI

Start following companies at Redeye to recieve the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment
Banking. https://www.redeye.se/about/

-----------------------------------------------------------
https://news.cision.com/se/speqta-ab/r/redeye-speqta--rahalaitos-makes-i...